BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18540169)

  • 21. A radiation resistance factor in cultured Cloudman S91 mouse melanoma cells.
    Hill HZ; Trizna Z; Ali M; Hill GJ
    Radiat Res; 1992 Jan; 129(1):43-7. PubMed ID: 1728056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does melanin affect the low LET radiation response of Cloudman S91 mouse melanoma cell lines?
    Hill HZ; Cathcart KN; Bargellini J; Trizna Z; Hill GJ; Schallreuter KU; Wood JM
    Pigment Cell Res; 1991 Mar; 4(2):80-6. PubMed ID: 1946213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
    Xia LJ; Han R
    Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of proliferation of cloudman S91 melanoma cells by insulin and characterization of some insulin-resistant variants.
    Kahn R; Murray M; Pawelek J
    J Cell Physiol; 1980 Apr; 103(1):109-19. PubMed ID: 7000797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
    Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and pigmentation in genetically related Cloudman S91 melanoma cell lines treated with 3-isobutyl-1-methyl-xanthine and beta-melanocyte-stimulating hormone.
    Cieszka KA; Hill HZ; Hill GJ; Plonka PM
    Exp Dermatol; 1995 Aug; 4(4 Pt 1):192-8. PubMed ID: 8535613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blue light inhibits melanin synthesis in B16 melanoma 4A5 cells and skin pigmentation induced by ultraviolet B in guinea-pigs.
    Ohara M; Kobayashi M; Fujiwara H; Kitajima S; Mitsuoka C; Watanabe H
    Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):86-92. PubMed ID: 15030593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental chemotherapy of murine melanomas: is there a discrepancy compared to clinical experience?
    Borovanský J
    Neoplasma; 1997; 44(5):277-81. PubMed ID: 9473785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma growth and tumorigenicity in models of microgravity.
    Taga M; Yamauchi K; Odle J; Furian L; Sundaresan A; Ramesh GT; Pellis NR; Andrassy RJ; Kulkarni AD
    Aviat Space Environ Med; 2006 Nov; 77(11):1113-6. PubMed ID: 17086762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of cell death induced by spermine and amine oxidase in mouse melanoma cells.
    Averill-Bates DA; Ke Q; Tanel A; Roy J; Fortier G; Agostinelli E
    Int J Oncol; 2008 Jan; 32(1):79-88. PubMed ID: 18097545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
    Jantová S; Letasiová S; Ovádeková R; Múcková M
    Neoplasma; 2006; 53(4):291-300. PubMed ID: 16830055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimelanogenesis effect of Tunisian herb Thymelaea hirsuta extract on B16 murine melanoma cells.
    Kawano M; Matsuyama K; Miyamae Y; Shinmoto H; Kchouk ME; Morio T; Shigemori H; Isoda H
    Exp Dermatol; 2007 Dec; 16(12):977-84. PubMed ID: 18031456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models.
    Siqueira JM; Gazola AC; Farias MR; Volkov L; Rivard N; de Brum-Fernandes AJ; Ribeiro-do-Valle RM
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):529-38. PubMed ID: 19184021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidine kinase in malignant melanoma.
    Borovanský J; Stríbrná J; Elleder M; Netíková I
    Melanoma Res; 1994 Oct; 4(5):275-9. PubMed ID: 7858409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic susceptibility and electron spin resonance absorption spectra of mouse melanomas S91 and 591A.
    Mulay IL; Mulay LN
    J Natl Cancer Inst; 1967 Oct; 39(4):735-43. PubMed ID: 18623933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination by EPR spectroscopy of free radicals in melanins isolated from A-375 cells exposed on valproic acid and cisplatin.
    Chodurek E; Zdybel M; Pilawa B; Dzierzewicz Z
    Acta Pol Pharm; 2012; 69(6):1334-41. PubMed ID: 23285699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of zinc on mouse melanoma growth in vitro and in vivo.
    Borovanský J; Riley PA; Vránková E; Necas E
    Neoplasma; 1985; 32(4):401-6. PubMed ID: 4047252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model.
    Averill-Bates DA; Chérif A; Agostinelli E; Tanel A; Fortier G
    Biochem Pharmacol; 2005 Jun; 69(12):1693-704. PubMed ID: 15935145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.
    Alemón-Medina R; Bravo-Gómez ME; Gracia-Mora MI; Ruiz-Azuara L
    Toxicol In Vitro; 2011 Jun; 25(4):868-73. PubMed ID: 21354300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.